These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29614980)

  • 41. Role of Chemoradiotherapy in Elderly Patients With Limited-Stage Small-Cell Lung Cancer.
    Corso CD; Rutter CE; Park HS; Lester-Coll NH; Kim AW; Wilson LD; Husain ZA; Lilenbaum RC; Yu JB; Decker RH
    J Clin Oncol; 2015 Dec; 33(36):4240-6. PubMed ID: 26481366
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of efficacy in adjuvant chemotherapy regimens in patients with radically resected gastric cancer : a propensity-matched analysis.
    Quan R; Huang J; Chen H; Liao Y; Lv W; Chen N; Liu J; Zhang H; Xu D
    Oncotarget; 2016 Nov; 7(46):76316-76326. PubMed ID: 27602756
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adjuvant chemoradiotherapy in gastric cancer: a pooled analysis of the AIRO gastrointestinal group experience.
    Mattiucci GC; Valentini C; D'Agostino GR; Augurio A; Capirci C; De Paoli A; Genovesi D; Huscher A; Iannone T; Pani G; Rosetto ME; Sciacero P; Manfrida S; Corazzi F; Fusco V; Luppattelli M; Mangiacotti MG; Melano A; Murino P; Niespolo R; Osti MF; Picardi V; Morganti AG; Valentini V
    Tumori; 2015; 101(1):91-7. PubMed ID: 25712602
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adjuvant chemoradiotherapy vs chemotherapy for resectable biliary tract cancer: a propensity score matching analysis based on the SEER database.
    Zhu Y; Liu X; Lin Y; Tang L; Yi X; Xu H; Yuan Y; Chen Y
    Eur J Med Res; 2023 Sep; 28(1):310. PubMed ID: 37658421
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Concurrent Versus Sequential Chemoradiation Therapy in Completely Resected Pathologic N2 Non-Small Cell Lung Cancer: Propensity-Matched Analysis of the National Cancer Data Base.
    Moreno AC; Haque W; Verma V; Fang P; Lin SH
    Ann Surg Oncol; 2018 May; 25(5):1245-1253. PubMed ID: 29484562
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Propensity Score Analysis of Radical Hysterectomy Versus Definitive Chemoradiation for FIGO Stage IIB Cervical Cancer.
    Tomita N; Mizuno M; Makita C; Kondo S; Mori M; Sakata J; Tsubouchi H; Hirata K; Tachibana H; Kodaira T
    Int J Gynecol Cancer; 2018 Oct; 28(8):1576-1583. PubMed ID: 30095702
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adjuvant Chemoradiotherapy in Resected Pancreatic Ductal Adenocarcinoma: Where Does the Benefit Lie? A Nomogram for Risk Stratification and Patient Selection.
    Naffouje SA; Sabesan A; Kim DW; Carballido E; Frakes J; Hodul P; Denbo JW; Malafa M; Fleming J; Hoffe S
    J Gastrointest Surg; 2022 Feb; 26(2):376-386. PubMed ID: 34506031
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Postoperative chemoradiotherapy versus chemotherapy for R0 resected gastric cancer with D2 lymph node dissection: an up-to-date meta-analysis.
    Zhou ML; Kang M; Li GC; Guo XM; Zhang Z
    World J Surg Oncol; 2016 Aug; 14(1):209. PubMed ID: 27502921
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adjuvant Therapy Use and Survival in Stage II Endometrial Cancer.
    Lester-Coll NH; Young MR; Park HS; Ratner ES; Litkouhi B; Damast S
    Int J Gynecol Cancer; 2017 Nov; 27(9):1904-1911. PubMed ID: 28763364
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phase I study of postoperative radiotherapy combined with capecitabine for gastric cancer.
    Wang X; Jin J; Li YX; Ren H; Fang H; Wang SL; Liu YP; Wang WH; Yu ZH; Song YW; Liu XF
    World J Gastroenterol; 2014 Jan; 20(4):1067-73. PubMed ID: 24574780
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study.
    Hsu CC; Herman JM; Corsini MM; Winter JM; Callister MD; Haddock MG; Cameron JL; Pawlik TM; Schulick RD; Wolfgang CL; Laheru DA; Farnell MB; Swartz MJ; Gunderson LL; Miller RC
    Ann Surg Oncol; 2010 Apr; 17(4):981-90. PubMed ID: 20087786
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phase II study of induction chemotherapy with gemcitabine plus 5-fluorouracil followed by gemcitabine-based concurrent chemoradiotherapy for unresectable locally advanced pancreatic cancer.
    Kurt E; Kurt M; Kanat O; Cetintas SK; Aygun S; Palazoglu T; Ozkan L; Evrensel T; Kaya E; Manavoglu O
    Tumori; 2006; 92(6):481-6. PubMed ID: 17260487
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Efficacy of Adjuvant FOLFOX6 for Patients With Gastric Cancer after D2 Lymphadenectomy: A Propensity Score-matched Analysis.
    Wang ZX; Yang XL; He MM; Wang F; Zhang DS; Li YH; Zhou ZW; Zhan YQ; Xu RH
    Medicine (Baltimore); 2016 Apr; 95(16):e3214. PubMed ID: 27100411
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combined treatment modalities in Pancoast tumor: results of a monocentric retrospective study.
    Jeannin G; Merle P; Janicot H; Thibonnier L; Kwiatkowski F; Naame A; Chadeyras JB; Galvaing G; Belliere A; Filaire M; Verrelle P
    Chin Clin Oncol; 2015 Dec; 4(4):39. PubMed ID: 26730751
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The addition of chemoradiation to adjuvant chemotherapy is associated with improved survival in lymph node-positive gastric cancer.
    Altman AM; Sheka AC; Marmor S; Lou E; Reynolds M; Hui JYC; Tuttle TM; Jensen EH; Denbo JW
    Surg Oncol; 2020 Sep; 34():134-139. PubMed ID: 32891318
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Efficacy of Adjuvant Chemotherapy in Patients With Stage II/III Resected Rectal Cancer Treated With Neoadjuvant Chemoradiation Therapy.
    Ahn DH; Wu C; Wei L; Williams TM; Wuthrick E; Abdel-Misih S; Harzman A; Husain S; Schmidt C; Goldberg RM; Bekaii-Saab T
    Am J Clin Oncol; 2017 Dec; 40(6):531-534. PubMed ID: 25723741
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial.
    Cats A; Jansen EPM; van Grieken NCT; Sikorska K; Lind P; Nordsmark M; Meershoek-Klein Kranenbarg E; Boot H; Trip AK; Swellengrebel HAM; van Laarhoven HWM; Putter H; van Sandick JW; van Berge Henegouwen MI; Hartgrink HH; van Tinteren H; van de Velde CJH; Verheij M;
    Lancet Oncol; 2018 May; 19(5):616-628. PubMed ID: 29650363
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adjuvant treatment for resected rectal cancer: impact of standard and intensified postoperative chemotherapy on disease-free survival in patients undergoing preoperative chemoradiation-a propensity score-matched analysis of an observational database.
    Garlipp B; Ptok H; Benedix F; Otto R; Popp F; Ridwelski K; Gastinger I; Benckert C; Lippert H; Bruns C
    Langenbecks Arch Surg; 2016 Dec; 401(8):1179-1190. PubMed ID: 27830368
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials.
    Oppedijk V; van der Gaast A; van Lanschot JJ; van Hagen P; van Os R; van Rij CM; van der Sangen MJ; Beukema JC; Rütten H; Spruit PH; Reinders JG; Richel DJ; van Berge Henegouwen MI; Hulshof MC
    J Clin Oncol; 2014 Feb; 32(5):385-91. PubMed ID: 24419108
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
    Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.